CDTX vs DAL
Cidara Therapeutics Inc (CDTX) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
CDTX currently screens at market cap $6.96B. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the CDTX and DAL stock pages for the full models.
Not investment advice.